Globe Life GL Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Net margin | 19.4%0.0pp | 19.4%0.0pp | 19.4%+1.3pp | 18.1%-0.2pp | 18.3%-0.2pp | |
| Free cash flow margin | 20.2%-0.7pp | 20.9%-0.1pp | 21%-1.9pp | 22.9%-1.2pp | 24.1%+1.1pp | |
| Returns | ||||||
| Return on equity | 20.5%-0.1pp | 20.6%-1.7pp | 22.3%+2.3pp | 20%-0.5pp | 20.5%-1.4pp | |
| Return on assets | 3.9%0.0pp | 3.9%0.0pp | 3.8%+0.2pp | 3.7%0.0pp | 3.7%-0.1pp | |
| Efficiency | ||||||
| Asset turnover | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.5×0.0× | 0.5×-0.1× | 0.5×-0.1× | 0.6×0.0× | 0.6×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Valuation | ||||||
| Market capitalization | $10.92B-1.9% | $11.13B-3.9% | $11.58B+14.2% | $10.15B-7.5% | $10.96B+17.1% | |
| Enterprise value | $13.9B-0.2% | $13.92B-3.3% | $14.39B+9.3% | $13.16B-6.1% | $14.01B+13.4% | |
| Price / earnings | 9.3×-0.3× | 9.6×-0.5× | 10.1×+0.5× | 9.5×-0.7× | 10.2×+1.5× | |
| Price / sales | 1.8×-0.1× | 1.9×-0.1× | 1.9×+0.2× | 1.7×-0.2× | 1.9×+0.3× | |
| Price / book | 1.8×-0.1× | 1.9×-0.2× | 2×+0.2× | 1.9×-0.1× | 2×+0.3× | |
| EV / sales | 2.3×0.0× | 2.3×-0.1× | 2.4×+0.2× | 2.2×-0.2× | 2.4×+0.3× | |
| Free cash flow yield | 11.3%0.0pp | 11.3%+0.5pp | 10.8%-2.5pp | 13.3%+0.4pp | 12.9%-1.4pp | |
| Earnings yield | 10.8%+0.4pp | 10.4%+0.5pp | 9.9%-0.6pp | 10.5%+0.7pp | 9.8%-1.7pp | |
| Dividend yield | 0.8%0.0pp | 0.8%0.0pp | 0.7%-0.1pp | 0.8%+0.1pp | 0.8%-0.1pp | |
| PEG ratio | 0.9×-0.2× | 1.1×-0.7× | 1.8×-2.9× | 4.7×+3.3× | 1.5×+0.6× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Globe Life's ratios come from?
- Every ratio is computed from Globe Life's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
